Thermo Fisher Scientific (TMO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 8 |
| Ownership rank: | 38 |
| % of all portfolios: | 0.265% |
| Hold Price * : | $497.60 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
2 |
$11,038 |
| Sells |
40 |
$44,697,587 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Lindsell Train |
7.01 |
Add 24.94% |
508,790 |
253,174,000 |
| ≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
4.42 |
|
75,000 |
37,320,000 |
| ≡ |
Polen Capital Management |
3.63 |
Reduce 5.64% |
2,322,482 |
1,155,667,000 |
| ≡ |
William Von Mueffling - Cantillon Capital Management |
2.91 |
Reduce 3.02% |
901,773 |
448,722,000 |
| ≡ |
AKO Capital |
2.15 |
Add 6.07% |
332,845 |
165,624,000 |
| ≡ |
David Katz - Matrix Asset Advisors |
0.86 |
Reduce 19.24% |
15,712 |
7,818,000 |
| ≡ |
Thomas Gayner - Markel Group |
0.20 |
Add 9.49% |
45,000 |
22,392,000 |
| ≡ |
Torray Funds |
0.03 |
|
403 |
201,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 21 Feb 2025 |
CHAI NELSON |
Director |
09 Dec 2024 |
4 |
535.93 |
2,144 |
| 21 Feb 2025 |
CHAI NELSON |
Director |
07 Nov 2024 |
16 |
555.89 |
8,894 |
| 06 Oct 2023 |
BOXER MICHAEL A |
SVP and General Counsel |
26 Jun 2023 |
4 |
526.15 |
2,105 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock